Efficacy of Drug Coated Balloon versus Drug Eluting Stent for Patients with De Novo Coronary Artery Disease: A Systematic Review and Meta-Analysis

This meta-analysis demonstrates comparable efficacy and safety outcomes for DCBs and DES in the treatment of de novo coronary artery disease. While DCBs offer a viable alternative, particularly for high-risk patients or those unsuitable for prolonged dual antiplatelet therapy, further large-scale studies are warranted to strengthen these findings and refine clinical recommendations. .